BR0212679A - Inibição de produção de exoproteìna usando composições aromáticas - Google Patents

Inibição de produção de exoproteìna usando composições aromáticas

Info

Publication number
BR0212679A
BR0212679A BR0212679-6A BR0212679A BR0212679A BR 0212679 A BR0212679 A BR 0212679A BR 0212679 A BR0212679 A BR 0212679A BR 0212679 A BR0212679 A BR 0212679A
Authority
BR
Brazil
Prior art keywords
unsaturated aliphatic
aliphatic hydrocarbyl
hydrocarbyl moiety
saturated
aromatic
Prior art date
Application number
BR0212679-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Rae Ellen Syverson
Richard A Proctor
Original Assignee
Kimberly Clark Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/969,299 external-priority patent/US20030135173A1/en
Priority claimed from US09/969,391 external-priority patent/US7022333B2/en
Priority claimed from US09/969,218 external-priority patent/US7026354B2/en
Application filed by Kimberly Clark Co filed Critical Kimberly Clark Co
Publication of BR0212679A publication Critical patent/BR0212679A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
BR0212679-6A 2001-10-02 2002-09-09 Inibição de produção de exoproteìna usando composições aromáticas BR0212679A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/969,299 US20030135173A1 (en) 2001-10-02 2001-10-02 Inhibition of exoprotein production in absorbent articles using aromatic compositions
US09/969,391 US7022333B2 (en) 2001-10-02 2001-10-02 Inhibition of exoprotein production in non-absorbent articles uisng aromatic compositions
US09/969,218 US7026354B2 (en) 2001-10-02 2001-10-02 Aromatic compositions for the inhibition of exoprotein production from gram positive bacteria
PCT/US2002/028756 WO2003030953A1 (en) 2001-10-02 2002-09-09 Inhibition of exoprotein production using aromatic compositions

Publications (1)

Publication Number Publication Date
BR0212679A true BR0212679A (pt) 2005-04-12

Family

ID=27420759

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0212679-6A BR0212679A (pt) 2001-10-02 2002-09-09 Inibição de produção de exoproteìna usando composições aromáticas

Country Status (9)

Country Link
EP (1) EP1432459A1 (ko)
JP (1) JP2005523239A (ko)
KR (1) KR100918887B1 (ko)
AR (1) AR037505A1 (ko)
AU (1) AU2002336472B2 (ko)
BR (1) BR0212679A (ko)
CA (1) CA2461291A1 (ko)
MX (1) MXPA04002474A (ko)
WO (1) WO2003030953A1 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009007799B4 (de) * 2009-02-06 2010-10-14 ITM Isotopen Technologien München AG Molekül zur Funktionalisierung eines Trägers, Bindung eines Radionuklids an den Träger und Radionuklidgenerator zur Herstellung des Radionuklids sowie Herstellungsverfahren
EP3223764B1 (en) * 2014-11-27 2023-10-25 Yeditepe Universitesi Antimicrobial and antiviral hygienic products
WO2018064978A1 (zh) * 2016-10-09 2018-04-12 曾忠铭 一种抑菌剂配伍在制备阴道用组合物中的用途与阴道用组合物

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317376A (en) * 1963-02-12 1967-05-02 Robert I Schattner Germicidal fabric
IL55214A (en) * 1978-07-25 1981-07-31 Abic Ltd Antibacterial compositions containing trimethoprim and other ingredients
DE3204124A1 (de) * 1982-02-06 1983-08-18 Bayer Ag, 5090 Leverkusen Antimykotische tampons mit hoher wirkstoff-freisetzung
US4560549A (en) * 1983-08-24 1985-12-24 Lever Brothers Company Method of relieving pain and inflammatory conditions employing substituted salicylamides
GB2186486B (en) * 1986-02-13 1989-11-08 Smith & Nephew Ass Antibacterial dressing
US5180749A (en) * 1989-08-22 1993-01-19 Sterling Winthrop, Inc. Antimicrobial composition
US5476455A (en) * 1993-01-11 1995-12-19 Silber; Arthur L. Toxicity resistant tampon structure
DE4411664A1 (de) * 1994-04-05 1995-10-12 Beiersdorf Ag Neue desodorierende und antimikrobielle Zusammensetzungen zur Verwendung in kosmetischen oder topischen Zubereitungen
JPH07289575A (ja) * 1994-04-27 1995-11-07 Okamoto Ind Inc 香料添加コンドーム及びコンドームへの香料添加方法
US5668097A (en) * 1994-08-12 1997-09-16 The Procter & Gamble Company Uncomplexed cyclodextrin solutions for odor control on inanimate surfaces
DE4434781A1 (de) * 1994-09-29 1996-04-04 Beiersdorf Ag Verwendung von Fettsäureestern zur Bekämpfung von Superinfektionen
AU6253996A (en) * 1995-06-07 1996-12-30 Kimberly-Clark Worldwide, Inc. Inhibition of exoprotein in absorbent article
JPH09108257A (ja) * 1995-10-23 1997-04-28 Shiyouichi Masugi 蓄光性クリーム及びラテックス製コンドーム
GB9612595D0 (en) * 1996-06-15 1996-08-21 Smithkline Beecham Plc Composition
WO1998011888A1 (en) * 1996-09-19 1998-03-26 American Home Products Corporation Method of treating urinary incontinence
ES2255730T3 (es) * 1997-04-18 2006-07-01 Ganeden Biotech, Inc. Utilizacion topica de esporas de bacilos probioticos para prevenir o tratar las infecciones microbianas.
KR20010013377A (ko) * 1997-06-04 2001-02-26 데이비드 엠 모이어 마일드한 잔류성 항균 조성물
US6353004B1 (en) * 1997-07-14 2002-03-05 Adolor Coporation Peripherally acting anti-pruritic opiates
AU5930898A (en) * 1998-01-28 1999-08-16 Procter & Gamble Company, The Antimicrobial hydrogel forming absorbent polymers
EP1024808A1 (en) * 1998-04-11 2000-08-09 Errekappa Euroterapici S.p.a. Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application
FR2777783A1 (fr) * 1998-04-24 1999-10-29 Innothera Lab Sa Association pharmaceutique d'imidazoles pour le traitement local des vulvo-vaginites infectieuses et des vaginoses
KR100563881B1 (ko) * 1998-05-29 2006-03-28 킴벌리-클라크 월드와이드, 인크. 천연 및 합성 중합체에 의한 향상된 냄새 흡수

Also Published As

Publication number Publication date
WO2003030953A1 (en) 2003-04-17
KR100918887B1 (ko) 2009-09-23
EP1432459A1 (en) 2004-06-30
CA2461291A1 (en) 2003-04-17
KR20040044950A (ko) 2004-05-31
JP2005523239A (ja) 2005-08-04
MXPA04002474A (es) 2004-05-31
AR037505A1 (es) 2004-11-17
AU2002336472B2 (en) 2007-08-23

Similar Documents

Publication Publication Date Title
BR0109851A (pt) Composto, método para produzir o mesmo ou um sal deste, pró medicamento, composição farmacêutica, método para inibir a tirosina cinase, método para prevenir ou tratar câncer, e, uso de um composto ou de um sal ou pró medicamento deste
BR0010555A (pt) Inibidores de neuraminidases
PT1254144E (pt) Novos compostos de fosforo
BR0014075A (pt) Inibidores de quinase como agentes terapêuticos
BRPI0906495B8 (pt) compostos derivados de indolil-piridona e composição farmacêutica
BR0213960A (pt) Tratamento de leucemia mileóide aguda com compostos de indolinona
BR0214096A (pt) Inibidores da pde9 para o tratamento de distúrbios cardiovasculares
BR0116468A (pt) Compostos de pirrolina substituìda por indazolila como inibidores de cinase
BR0211750A (pt) Agente antiviral
BR9913654A (pt) Inibidores de p-38alfa quinase
ES2169871T3 (es) Empleo de poliacidos para el tratamiento de fertilizantes minerales que contienen un inhibidor de nitrificado.
BR0308495A (pt) Composto, formulação farmacêutica, métodos para ativar receptores de 5-ht1f, para inibir o extravasamento de proteìna neuronal, para tratar ou prevenir enxaqueca em um mamìfero e para preparar um composto, uso de um composto, e, processo para preparar um composto
BR9813835A (pt) Composto, composição farmacêutica e método de tratamento ou prevenção de uma desordem tromboembólica
BR0113629A (pt) Inibidores da adesão celular mediada por alfa4
BRPI0510059A (pt) inibidores da transcriptase reversa não-nucleosìdica
WO2005089256A3 (en) Antiangiogenic agents
WO2008006718A3 (en) Synergistic anti-microbial mixtures of tropolone (derivatives) and selected compounds
ATE301460T1 (de) Zubereitung zur prophylaxe oder behandlung der demenz-erkrankung enthaltend ein hydroxyzimtsäurederivat oder einen extrakt einer pflanze der gattung angelica, der diese säure enthält.
GB1392044A (en) Corrosion inhibiting composition
BR0113389A (pt) Compostos que inibem a atividade do fator xa
BR0212679A (pt) Inibição de produção de exoproteìna usando composições aromáticas
DE60002558D1 (de) Derivate der Phosphonsäure zur Inhibierung von Carboxypeptidase B
WO1999035133A3 (en) 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid derivatives as chelating agents
ATE172749T1 (de) Waschmittelzusammensetzungen zur verhinderung der farbstoffübertragung
MXPA02012481A (es) Benzoxazepinonas y su uso como inhibidores de escualeno sintasa.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2144 DE 07/02/2012.